WTP high for raltitrexed vs standard therapy in colorectal cancer

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.380, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WTP high for raltitrexed vs standard therapy in colorectal cancer

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer

By Aristides M.

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 775-784

Adis International

Access to resources Recommend Favorite

Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid

By Sculpher M.

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Bevacizumab an improvement on standard therapy in colorectal cancer

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Inferior QOL effect with raltitrexed for colorectal cancer

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite